Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

At the midpoint of her term as 2023-2024 ASCO president, Dr. Lynn M. Schuchter highlights key points of progress from 2023 and looks toward a busy year ahead.
"Unless we take prompt action to protect rural oncologists from threats related to Dobbs, there will be few left to treat rural patients with cancer," said Dr. Banu E. Symington.
Welcome to the first issue of ASCO Connection in 2023—we are kicking off the new year with a wide-ranging issue.
ASCO’s delegation to the American Medical Association’s House of Delegates (AMA HOD) recently traveled to Honolulu for the Interim meeting. Our resolutions primarily focused on the threat of legislation that could criminalize medically necessary care in the wake of the Supreme Court’s decision...
A diverse workforce will benefit all of our patients by exposing us all to new and different ideas, allowing culturally competent care, and ultimately improving cancer care for all patients.
Mingqian Lin and Yixuan James Zheng add their voices to ASCO's call to action on equity, diversity, and inclusion, and draw attention to the specific challenges faced by the AANHPI population in the United States.
Let's consider the progress that has been made as well as the work that still needs to be done to reach gender equity in our profession.
What do we mean when we say that equity, diversity, and inclusion is not one thing, it’s everything?
The AMA House of Delegates adopted a resolution to remain committed with increased efforts against the resumption of the sequestration payment applied to all Medicare fee-for-service claims.
Dr. Atlal Abusanad discusses how biases in valuing capability and potential in female oncologists has led to their underrepresentation in prominent roles. 
ASCO’s delegation to the American Medical Association (AMA) recently met virtually with the AMA’s House of Delegates (HOD), with a focus on payment reform models. 
Despite the virtual nature of the AMA House of Delegates meeting, the decisions made there have a very real impact on our profession and the patients we serve.
My colleague and friend Ginny Mason and I discuss advocacy, "beating the odds," and her perspective 26 years out from an initial diagnosis of inflammatory breast cancer.
ASCO president Dr. Lori J. Pierce and I discuss her background, her presidential theme, and ASCO efforts related to health equity and representation.
Although our societal meetings, including the AMA House of Delegates meeting, are shortened, they have never been more important than they are at this moment.
A spirit of clinically relevant discovery and accessible, understandable knowledge dissemination is the profound legacy, responsibility, and obligation that Rich will leave at ASCO, and we will honor him by continuing this work at the level of rigor and quality he established.
We must commit the same energy and focus we pour into conquering cancer to addressing systemic issues that affect the health of people of color in our country.
Dr. Ray Page and I discuss the important role that drug repository programs can play in helping our patients afford their treatment while reducing the financial toll on the cancer care delivery system.

Pages


Advertisement